Cargando…
Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
The current diagnosis of Parkinson’s disease (PD) mostly relies on clinical rating scales related to motor dysfunction. Given that clinical symptoms of PD appear after significant neuronal cell death in the brain, it is required to identify accessible, objective, and quantifiable biomarkers for earl...
Autores principales: | Kang, Juhee, Kim, Jae Whan, Heo, Hansol, Lee, Jihyun, Park, Kwan Yong, Yoon, Jung Han, Chang, Jaerak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993325/ https://www.ncbi.nlm.nih.gov/pubmed/33202088 http://dx.doi.org/10.1111/cts.12920 |
Ejemplares similares
-
Identification of Cathepsin D as a Plasma Biomarker for Alzheimer’s Disease
por: Kim, Jae-Whan, et al.
Publicado: (2021) -
Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD
por: Nakajima, Takahiro, et al.
Publicado: (2016) -
Identification of BAG5 as a Potential Biomarker for Parkinson’s Disease Patients With R492X PINK1 Mutation
por: Fu, Yu, et al.
Publicado: (2022) -
Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism
por: Yelamanchili, Sowmya V, et al.
Publicado: (2011) -
In-bag power morcellation technique in single-port laparoscopic myomectomy
por: Won, Young Bin, et al.
Publicado: (2018)